Boundless Bio: Tang Capital reports 12.5% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Boundless Bio, Inc. (BOLD) is the subject of an amended beneficial-ownership report in which Tang Capital Management, LLC and Kevin Tang each report beneficial ownership of 2,840,635 shares, or 12.5% of the class, with shared voting and dispositive power. Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc. report separate beneficial-ownership amounts of 655,170, 887,715, 655,161, and 642,589 shares, respectively.
Kevin Tang is identified as manager of Tang Capital Management and chief executive officer of Tang Capital Partners III and IV. The report describes the voting and dispositive power as shared among the reporting persons and related entities.
Key Figures
Key Terms
beneficially owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.